es flag go to the original language article
This article has been translated by Artificial Intelligence (AI). The news agency is not responsible for the content of the translated article. The original was published by Europa Press.

Spain will provide 100,000 vials of the Mpox vaccine to Africa with doses for 500,000 people

by AI | 27.Aug 2024 | Europe in brief AI

The Ministry of Health reported on Tuesday that Spain has informed the European Commission that it will donate 20 percent of its vaccine stock, that is, 100,000 vials which would provide 500,000 doses for vaccination.

A laboratory technician works with PCR tests in the Microbiology Laboratory of the public hospital Gregorio Marañón, on May 31, 2022, in Madrid (Spain). Photo: Eduardo Parra / Europa Press

The Ministry of Health reported this Tuesday that Spain has informed the European Commission that it will donate 20 percent of its vaccine stock, that is, 100,000 vials that would be enough to vaccinate with 500,000 doses.

The Public Health Emergency of International Concern of Mpox has its epicenter in several countries in central Africa and Health considers it essential to act in this region to contain the current situation in a solid and firm way, so that the situation of 2022-2023 in which the international emergency “was prematurely closed” does not repeat.

The European Commission has announced that it will donate 215,000 vaccines. It is believed that about two million vials are needed to vaccinate, with about 10 million doses to contain the current situation. Therefore, the Spanish Government urges the European Commission to extend the proposal to all member states to donate 20 percent of their vaccine stock to address the current situation.

In recent months, the Pandemic Agreement has been being negotiated within the framework of the World Health Organization (WHO) and the drafts that have been published contemplate donation scenarios for pandemic situations that, according to the Ministry of Health, must be implemented in the current Mpox situation.

For this reason, it is considered that “there is no sense in accumulating vaccines where the problem is not, and now is the time to demonstrate it”.